By Krishna SinlapasaJune 29, 2026 Inhibition of tumor growth by β-glucans through promoting CD4+ T cell immunomodulation and neutrophil-killing in mice + Read More
By Krishna SinlapasaJune 29, 2026 Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles + Read More
By Krishna SinlapasaJune 29, 2026 Oral administration of botryosphaeran [(1 → 3)(1 → 6)‐β‐d‐glucan] reduces inflammation through modulation of leukocytes and has limited effect on inflammatory nociception + Read More
By Krishna SinlapasaJune 29, 2026 Oral administration of the β-glucan produced by Aureobasidium pullulans ameliorates development of atherosclerosis in apolipoprotein E deficient mice + Read More
